Sulfacetamide sodium
 OpenBabel02212023462D

 15 14  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 Na  0  3  0  0  0 15  0  0  0  0  0  0
    2.7180    2.6518    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7180    1.8268    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0036    1.4143    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.4325    1.4143    0.0000 N   0  5  0  0  0  0  0  0  0  0  0  0
    3.4325    0.5893    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    2.6075    0.5893    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.2575    0.5893    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.4325   -0.2357    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1470   -0.6482    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1470   -1.4732    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4325   -1.8857    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4325   -2.7107    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.7180   -1.4732    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7180   -0.6482    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  3  1  0  0  0  0
  3  4  2  0  0  0  0
  3  5  1  0  0  0  0
  5  6  1  0  0  0  0
  6  7  2  0  0  0  0
  6  8  2  0  0  0  0
  6  9  1  0  0  0  0
  9 10  2  0  0  0  0
  9 15  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  2  0  0  0  0
 12 13  1  0  0  0  0
 12 14  1  0  0  0  0
 14 15  2  0  0  0  0
M  CHG  2   1   1   5  -1
M  END
>  <CdId>
125

>  <Mol Weight>
236.223

>  <Formula>
C8H9N2NaO3S

>  <ID>
T0087L

>  <Name>
Sulfacetamide sodium

>  <Synonyms>
Sulamyd sodium

>  <CAS>
127-56-0

>  <Approved status>
FDA

>  <Disease>
Immune system

>  <Indication>
Seborrhoeic Dermatitis

>  <Pathways>
Autophagy

>  <Target>
Autophagy inhibitor

>  <Receptor>
Autophagy

$$$$
